Univ. Lille, CHU Lille, ULR 2694 METRICS-Evaluation des technologies de santé et des pratiques médicales, F-59000, Lille, France.
Inserm, CIC-IT 1403, Centre d'Investigation Clinique, F-59000, Lille, France.
Eur Geriatr Med. 2021 Jun;12(3):499-507. doi: 10.1007/s41999-021-00449-9. Epub 2021 Feb 13.
Older people are frequently exposed to polypharmacy, inappropriate prescribing, and adverse drug events. Two clinical processes can help geriatricians to optimize and increase the safety of drug prescriptions for older adults: medication reconciliation and medication review. Medication reconciliation provides the best possible medication history and identifies and resolves discrepancies in drug prescriptions. During the medication review, the best possible medication history is crosschecked against other data, including morbidities, patient's preferences, or geriatric syndromes, to produce a personalized medication strategy. Alignment of treatment recommendations with patient preferences and goals through shared decision-making is particularly important in medication review. Medication reconciliation and medication review have proven to be effective, but their broad implementation remains difficult. Indeed, these procedures are time-consuming and require specific skills, coordination between different healthcare professionals, organizations and dedicated means. The involvement of geriatricians therefore remains essential for the successful implementation of medication reconciliation and medication review in geriatric settings and among frail older people.
老年人经常面临多种药物治疗、不适当的处方和药物不良事件。两种临床过程可以帮助老年病医生优化和提高老年人药物处方的安全性:药物重整和药物审查。药物重整提供了尽可能好的药物史,并识别和解决药物处方中的差异。在药物审查过程中,最好的药物史与其他数据(包括疾病、患者偏好或老年综合征)进行交叉核对,以制定个性化的药物策略。通过共同决策使治疗建议与患者的偏好和目标保持一致,在药物审查中尤为重要。药物重整和药物审查已被证明是有效的,但它们的广泛实施仍然很困难。实际上,这些程序既耗时又需要特定的技能,需要不同医疗保健专业人员、组织和专门手段之间的协调。因此,老年病医生的参与对于在老年环境中和体弱老年人中成功实施药物重整和药物审查仍然至关重要。